Published in J Med Imaging Radiat Oncol on August 01, 2010
Case series are no substitute for randomised placebo-controlled trials for determination of treatment efficacy. J Med Imaging Radiat Oncol (2010) 1.39
Is vertebroplasty a risk factor for subsequent vertebral fracture, meta-analysis of published evidence? Osteoporos Int (2014) 0.84
The biocompatibility of porous vs non-porous bone cements: a new methodological approach. Eur J Histochem (2014) 0.76
Outcomes and National Trends for the Surgical Treatment of Lumbar Spine Trauma. Biomed Res Int (2016) 0.75
Spinal Compression Fracture Management: A Review of Current Treatment Strategies and Possible Future Avenues. Global Spine J (2017) 0.75
Monoclonal gammopathy: benign or not? Aust N Z J Med (1999) 2.03
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases. Proc Natl Acad Sci U S A (1994) 1.58
Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med (1992) 1.56
IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. J Immunol (1992) 1.33
Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol (1998) 1.30
Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.10
Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum (1997) 1.10
Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem (1992) 1.09
Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. J Biol Chem (1993) 1.01
Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J Immunol (1994) 1.00
Deglacial pulses of deep-ocean silicate into the subtropical North Atlantic Ocean. Nature (2013) 0.99
A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14. J Biol Chem (1993) 0.98
Coincidence Counting in Time-of-Flight Mass Spectrometry: A Test for Chemical Microhomogeneity. Science (1990) 0.96
Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium. Arthritis Rheum (1997) 0.93
Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2007) 0.91
Antiphospholipid antibodies--new insights into their specificity and clinical importance. Scand J Immunol (1992) 0.90
Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome. J Immunol (1999) 0.88
Role of alcohol in the aetiology of hypertension. Med J Aust (1980) 0.88
Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis (1998) 0.87
Airway inflammation in a murine model of chronic asthma: evidence for a local humoral immune response. Clin Exp Allergy (2000) 0.83
Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin 1. Biochim Biophys Acta (1996) 0.83
New aspects of anticardiolipin antibodies. Clin Exp Rheumatol (1991) 0.82
C-reactive protein contributes to the hypercoagulable state in coronary artery disease. J Thromb Haemost (2006) 0.82
HLA-DR antigens and anticardiolipin antibodies. Clin Exp Rheumatol (1990) 0.78
Headache as the initial presentation of Wegener's granulomatosis. Ann Rheum Dis (2002) 0.78
An IL-3-induced splenic NC-1.1+ mast cell line mediates natural cytotoxicity independent of TNF-alpha. Cell Immunol (1996) 0.78
What can we learn from the synovium in early rheumatoid arthritis? Inflamm Res (2002) 0.78
Retracted Monocyte tissue factor induction by activation of beta 2-glycoprotein-I-specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies. J Immunol (2000) 0.77
An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis. Clin Exp Rheumatol (2014) 0.77
Acute gout management during hospitalization: a need for a protocol. Intern Med J (2010) 0.77
Enhancing academic physician training. Intern Med J (2008) 0.75
The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al. Arthritis Rheum (2001) 0.75
Recent insights into antiphospholipid antibody-mediated thrombosis. Baillieres Best Pract Res Clin Haematol (1999) 0.75
Nursery pig growth performance and tissue accretion modulation due to porcine epidemic diarrhea virus or porcine deltacoronavirus challenge. J Anim Sci (2017) 0.75
Expression of the alphaEbeta7 integrin by mast cells in rheumatoid synovium. J Rheumatol (2000) 0.75